All In Biotech

Drug Trial Radar · NCT01688011

Connect® Myeloid Disease Registry

Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Last checked: Nov 19, 2026Latest source record: Jul 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

2,013

Actual

Start

Dec 12, 2013

Primary completion

Oct 18, 2024

Study completion Oct 18, 2024

Sponsor

Lead sponsor
CelgeneBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Sep 19, 2012

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the Connect® Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification which may or may not be predictive of therapy and clinical outcomes.

Conditions

  • Primary Myelofibrosis
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute

Interventions

  • LuspaterceptDrug

    Prescribed by treating physician as per product label.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient Demographics- MDS/AML/ICUS CohortsTime frame: Up to 8 years
  2. Diagnostic and Treatment Patterns- MDS/AML/ICUS CohortsTime frame: Up to 8 years
  3. Safety and Effectiveness- MDS/AML/ICUS CohortsTime frame: Up to 8 years
  4. Patient Demographics- MF CohortTime frame: Up to 5 years
  5. Diagnostic and Treatment Patterns- MF CohortTime frame: Up to 5 years
  6. Safety and Effectiveness- MF CohortTime frame: Up to 5 years
  7. Treatment effectiveness - LTCTime frame: Minimum of 3-months post index date
  8. Treatment patterns and clinical outcomes - LTC CohortTime frame: Minimum of 3-months post index date
  9. Transfusion information - LTCTime frame: Minimum of 3-months post index date
  10. Treatment duration - LTC CohortTime frame: Minimum of 3-months post index date

Locations

158 sites in 2 countries. Site status is shown where the registry gives one.

  • DCH Health System (Lewis and Faye Manderson Cancer Center)

    Tuscaloosa, Alabama

  • Arizona Oncology

    Phoenix, Arizona

  • The University of Arizona Cancer Center

    Tucson, Arizona

  • Local Institution - 1273

    Tucson, Arizona

  • Highlands Oncology Group

    Fayetteville, Arkansas

  • Clopton Clinic of Jonesboro, Inc.

    Jonesboro, Arkansas

  • NEABC- Fowler Family Center for Cancer Care

    Jonesboro, Arkansas

  • Local Institution - 1161

    Jonesboro, Arkansas

  • Comprehensive Blood & Cancer Center

    Bakersfield, California

  • Alta Bates Summit Comprehensive Cancer

    Berkeley, California

  • Sutter East Bay Hospitals (dba Jordan Research and Education Institute - REDI)

    Berkeley, California

  • John Muir Clinical Research Center

    Concord, California

  • VA Central California Health Care System

    Fresno, California

  • UCSD Moores Cancer Center

    La Jolla, California

  • Pacific Cancer Care

    Monterey, California

  • Local Institution - 1016

    San Diego, California

  • Local Institution - 1027

    Santa Rosa, California

  • St. Joseph's Regional Cancer Center

    Stockton, California

  • Saint Joseph Hospital, Cancer Centers of Colorado

    Denver, Colorado

  • Regional Cancer Care Associates

    Manchester, Connecticut

  • Bennett Cancer Center Stamford Hospital

    Stamford, Connecticut

  • Delaware Clinical and Laboratory Physicians

    Christiana, Delaware

  • University Cancer Institute

    Boynton Beach, Florida

  • Halifax Health Center for Oncology

    Daytona Beach, Florida

  • Holy Cross Hospital

    Fort Lauderdale, Florida

  • University of Florida

    Gainesville, Florida

  • Cancer Specialists of North Florida

    Jacksonville, Florida

  • Watson Clinic Center for Cancer Care and Research

    Lakeland, Florida

  • Ocala Oncology

    Ocala, Florida

  • Adventist Health System/Sunbelt, Inc.

    Orlando, Florida

  • Memorial Healthcare System

    Pembroke Pines, Florida

  • Sacred Heart Medical Oncology Group

    Pensacola, Florida

  • Georgia Regents University Cancer Center

    Augusta, Georgia

  • Southeast Georgia Health System

    Brunswick, Georgia

  • Columbus Regional Research Institute

    Columbus, Georgia

  • Northwest Georgia Oncology Centers, P.C.

    Marietta, Georgia

  • Saint Alphonsus Regional Medical Center

    Boise, Idaho

  • RUSH University Cancer Center

    Chicago, Illinois

  • NorthShore University Health System

    Evanston, Illinois

  • Ingalls Memorial Hospital

    Harvey, Illinois

Showing 40 of 158 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.